Oxford Nanopore Technologies develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA and proteins.
We're developing & manufacturing innovative gene-based medicines in ophthalmology, CNS & cancer.
Scancell Holdings plc develops immunotherapies for the treatment of cancer.
Oxehealth develops a non-contact vital signs technology to support medical and non-medical applications.
Circassia is a specialty biopharmaceutical company focused on developing novel immunotherapies
OXGENE (also known as Oxford Genetics) is a synthetic biology company.
Physiomics develops computer simulation technology to understand and predict patient responses to pharmaceuticals.
Oxford BioDynamics Plc, a biotechnology company, discovers and develops novel biomarkers.
Sensyne Health provides software solutions.
Vaccitech is a spin-out company renowned vaccine research center.
Orbit Discovery is a peptide display technology company that identifies peptide drugs for chronic diseases.
Ultromics develops echocardiography software that enables healthcare providers to improve the diagnosis of coronary heart disease.